4
Changes in Ownership
RESMED INC Filed Acc 0001127602-22-012108
President and COO sold 8,000 shares at $233.29 ($1,866,320)
- President and COO acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Douglas Robert Andrew President and COO | 2022-04-18 | Option exercise | +8,000 | $58.24 | $465,920 | 25,175 | D: show line 1 in the form |
| Douglas Robert Andrew President and COO | 2022-04-18 | Sale | −8,000 | $233.29 | $1,866,320 | 17,175 | D: show line 2 in the form |
| Open-market sales · 8,000 sh · avg $233.29 · $1,866,320 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Douglas Robert Andrew President and COO | 2022-04-18 | Option exercise · ResMed Common Stock Options | −8,000 | 54,098 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…